Jefferies Group LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 176 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 10.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$7,139,670
+1937.5%
189,532
+820.1%
0.06%
+2000.0%
Q4 2020$350,406
+163.5%
20,600
-6.4%
0.00%
+200.0%
Q2 2019$133,000
-61.2%
22,016
-13.8%
0.00%
-66.7%
Q1 2019$343,000
+16.3%
25,550
-19.4%
0.00%
+50.0%
Q4 2018$295,000
+54.5%
31,696
+131.3%
0.00%
+100.0%
Q3 2018$191,000
-5.9%
13,704
+144.6%
0.00%
-50.0%
Q1 2017$203,000
-88.5%
5,602
-83.4%
0.00%
-77.8%
Q3 2016$1,768,000
+8.0%
33,700
-14.9%
0.01%
+12.5%
Q2 2016$1,637,00039,6000.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders